Kimia Farma (Indonesia) Investor Sentiment

KAEF Stock  IDR 605.00  5.00  0.82%   
About 62% of Kimia Farma's investor base is looking to short. The analysis of current outlook of investing in Kimia Farma Persero suggests that many traders are alarmed regarding Kimia Farma's prospects. Kimia Farma's investing sentiment shows overall attitude of investors towards Kimia Farma Persero.
  
over two months ago at news.google.com         
Indonesia shares higher at close of trade Jakarta Stock Exchange Composite up 0.02 percent - Investi...
Google News at Macroaxis
over three months ago at news.google.com         
Indonesias SOE Ministry Replaces Kimia Farma President, Directors - Tempo.co English
Google News at Macroaxis
over three months ago at news.google.com         
Indonesias SOE Ministry Replaces Kimia Farma President, Directors - Tempo.co English
Google News at Macroaxis
over six months ago at news.google.com         
Global Quinine Hydrochloride API Market 2024 Research Report by Company Details, Application, Produc...
Google News at Macroaxis
over six months ago at news.google.com         
BUMN Kimia Farma Tbk Membuka Lowongan Kerja Untuk Lulusan SMA - SMK Januari 2024 - Batas Timor - Bat...
Google News at Macroaxis
over six months ago at news.google.com         
Senin, Kimia Farma Mulai Buka Klinik Vaksinasi Individu - News Solopos.com
Google News at Macroaxis
over a year ago at news.google.com         
PT Kimia Farma Trading Distribution Buka Loker, Cek Di Sini - Berita Satujuang
Google News at Macroaxis
over a year ago at news.google.com         
Begini Bocoran Dirut Kimia Farma soal Rencana IPO Anak Usaha - Bisnis.com
Google News at Macroaxis
over a year ago at news.google.com         
Stock Split BBNI Pecahkan Rekor Tertinggi, Pengamat Penguatan Kinerja Saham - PR INDONESIA - pr indo...
Google News at Macroaxis
over a year ago at news.google.com         
KlikDokter, Kalbe Farma dan Kimia Farma Kolaborasi untuk ... - KlikDokter
Google News at Macroaxis
over a year ago at news.google.com         
Kimia Farma Kalbe Sinergi Layanan Kesehatan Berbasis Digital - Medcom.Id
Google News at Macroaxis
over a year ago at news.google.com         
Biofarma MIT Hacking Medicine Hadirkan Solusi Layanan ... - Biofarma
Google News at Macroaxis
over a year ago at news.google.com         
Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking ... - ACROFAN USA
Google News at Macroaxis
over a year ago at news.google.com         
Berkolaborasi dengan MIT - Biofarma
Google News at Macroaxis
over a year ago at news.google.com         
Tesla dips after Q1 deliveries report analyst reactions mixed By ... - Investing.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Kimia Farma that are available to investors today. That information is available publicly through Kimia media outlets and privately through word of mouth or via Kimia internal channels. However, regardless of the origin, that massive amount of Kimia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kimia Farma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kimia Farma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kimia Farma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kimia Farma alpha.

Kimia Farma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Other Information on Investing in Kimia Stock

Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.